Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murray, N.
Right arrow Articles by Dixon, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murray, N.
Right arrow Articles by Dixon, P.

Journal of Clinical Oncology, Vol 11, 336-344, Copyright © 1993 by American Society of Clinical Oncology

ARTICLES

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

N Murray, P Coy, JL Pater, I Hodson, A Arnold, BC Zee, D Payne, EC Kostashuk, WK Evans and P Dixon
British Columbia Cancer Agency Vancouver Clinic, Canada.

PURPOSE: The importance of the timing of thoracic irradiation (TI) in the combined modality therapy of limited-stage small-cell lung cancer (SCLC) was assessed in a randomized trial. METHODS: All 308 eligible patients received cyclophosphamide, doxorubicin, and vincristine (CAV) alternating with etoposide and cisplatin (EP) every 3 weeks for three cycles of each chemotherapy regimen. Patients randomized to early TI received 40 Gy in 15 fractions over 3 weeks to the primary site concurrent with the first cycle of EP (week 3), and late TI patients received the same radiation concurrent with the last cycle of EP (week 15). After completion of all chemotherapy and TI, patients without progressive disease received prophylactic cranial irradiation (25 Gy in 10 fractions over 2 weeks). RESULTS: Although complete remission rates were not significantly different between the two arms, progression-free survival (P = .036) and overall survival (P = .008) were superior in the early TI arm. Patients in the late TI arm had a higher risk of brain metastases (P = .006). CONCLUSION: The early administration of TI in the combined modality therapy of limited-stage SCLC is superior to late or consolidative TI.


This article has been cited by other articles:


Home page
 Tobacco ControlHome page
S A Kenfield, E K Wei, M J Stampfer, B A Rosner, and G A Colditz
Comparison of aspects of smoking among the four histological types of lung cancer
Tob. Control, June 1, 2008; 17(3): 198 - 204.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. A. Socinski and J. A. Bogart
Limited-Stage Small-Cell Lung Cancer: The Current Status of Combined-Modality Therapy
J. Clin. Oncol., September 10, 2007; 25(26): 4137 - 4145.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. J. Samson, J. Seidenfeld, G. R. Simon, A. T. Turrisi III, C. Bonnell, K. M. Ziegler, and N. Aronson
Evidence for Management of Small Cell Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 314S - 323S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. R. Simon and A. Turrisi
Management of Small Cell Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 324S - 339S.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. Laurie, K Ding, M Whitehead, R Feld, N Murray, F. Shepherd, and L Seymour
The impact of anemia on outcome of chemoradiation for limited small-cell lung cancer: a combined analysis of studies of the National Cancer Institute of Canada Clinical Trials Group
Ann. Onc., June 1, 2007; 18(6): 1051 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
D De Ruysscher, C Dehing, R-H Bremer, S. Bentzen, F Koppe, M Pijls-Johannesma, L Harzee, A Minken, R Wanders, M Hochstenbag, et al.
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients
Ann. Onc., May 1, 2007; 18(5): 909 - 916.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. C. Perry
Thoracic Radiation Therapy in Limited Stage Small-Cell Lung Cancer: Timing Is Everything...Isn't It?
J. Clin. Oncol., August 20, 2006; 24(24): 3815 - 3816.
[Full Text] [PDF]

Home page
 JCOHome page
S. G. Spiro, L. E. James, R. M. Rudd, C. W. Trask, J. S. Tobias, M. Snee, D. Gilligan, P. A. Murray, M. C. R. de Elvira, K. M. O'Donnell, et al.
Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis
J. Clin. Oncol., August 20, 2006; 24(24): 3823 - 3830.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. A. Bogart, S. L. Seagren, and A. Glicksman
Radiation oncology research in the cancer and leukemia group B.
Clin. Cancer Res., June 1, 2006; 12(11): 3628s - 3634s.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
D. De Ruysscher, M. Pijls-Johannesma, J. Vansteenkiste, A. Kester, I. Rutten, and P. Lambin
Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer
Ann. Onc., April 1, 2006; 17(4): 543 - 552.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. M. Brade and I. F. Tannock
Scheduling of Radiation and Chemotherapy for Limited-Stage Small-Cell Lung Cancer: Repopulation As a Cause of Treatment Failure?
J. Clin. Oncol., March 1, 2006; 24(7): 1020 - 1022.
[Full Text] [PDF]

Home page
 JCOHome page
D. De Ruysscher, M. Pijls-Johannesma, S. M. Bentzen, A. Minken, R. Wanders, L. Lutgens, M. Hochstenbag, L. Boersma, B. Wouters, G. Lammering, et al.
Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer
J. Clin. Oncol., March 1, 2006; 24(7): 1057 - 1063.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Thatcher, W. Qian, P. I. Clark, P. Hopwood, R. J. Sambrook, R. Owens, R. J. Stephens, and D. J. Girling
Ifosfamide, Carboplatin, and Etoposide With Midcycle Vincristine Versus Standard Chemotherapy in Patients With Small-Cell Lung Cancer and Good Performance Status: Clinical and Quality-of-Life Results of the British Medical Research Council Multicenter Randomized LU21 Trial
J. Clin. Oncol., November 20, 2005; 23(33): 8371 - 8379.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. Movsas
Will Future Progress in Non-Small-Cell Lung Cancer Be Step by Step ... or by Leaps and Bounds?
J. Clin. Oncol., September 1, 2005; 23(25): 5859 - 5861.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. G. Spiro and G. A. Silvestri
One Hundred Years of Lung Cancer
Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 523 - 529.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Kubota, Y. Nishiwaki, T. Sugiura, K. Noda, K. Mori, M. Kawahara, S. Negoro, K. Watanabe, F. Imamura, T. Tamura, et al.
Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903
Clin. Cancer Res., August 1, 2005; 11(15): 5534 - 5538.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Singh, W. Parulekar, N. Murray, R. Feld, W. K. Evans, D. Tu, and F. A. Shepherd
Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer
J. Clin. Oncol., February 1, 2005; 23(4): 850 - 856.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. Ragaz, I. A. Olivotto, J. J. Spinelli, N. Phillips, S. M. Jackson, Kenneth. S. Wilson, M. A. Knowling, C. M. L. Coppin, L. Weir, K. Gelmon, et al.
Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial
J Natl Cancer Inst, January 19, 2005; 97(2): 116 - 126.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. B. Fried, D. E. Morris, C. Poole, J. G. Rosenman, J. S. Halle, F. C. Detterbeck, T. A. Hensing, and M. A. Socinski
Systematic Review Evaluating the Timing of Thoracic Radiation Therapy in Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer
J. Clin. Oncol., December 1, 2004; 22(23): 4837 - 4845.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. Huncharek and R. McGarry
A Meta-Analysis of the Timing of Chest Irradiation in the Combined Modality Treatment of Limited-Stage Small Cell Lung Cancer
Oncologist, November 1, 2004; 9(6): 665 - 672.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Q.-T. Le, J. McCoy, S. Williamson, J. Ryu, L. E. Gaspar, M. J. Edelman, S. R. Dakhil, S. D. Sides, J. J. Crowley, and D. R. Gandara
Phase I Study of Tirapazamine Plus Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer (S0004): A Southwest Oncology Group Study
Clin. Cancer Res., August 15, 2004; 10(16): 5418 - 5424.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. Spira and D. S. Ettinger
Multidisciplinary Management of Lung Cancer
N. Engl. J. Med., January 22, 2004; 350(4): 379 - 392.
[Full Text] [PDF]

Home page
 JCOHome page
M. J. Edelman, K. Chansky, L. E. Gaspar, B. Leigh, G. R. Weiss, S. A. Taylor, J. Crowley, R. Livingston, and D. R. Gandara
Phase II Trial of Cisplatin/Etoposide and Concurrent Radiotherapy Followed by Paclitaxel/Carboplatin Consolidation for Limited Small-Cell Lung Cancer: Southwest Oncology Group 9713
J. Clin. Oncol., January 1, 2004; 22(1): 127 - 132.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
S.-H. Lee, Y. C. Ahn, H. J. Kim, D. H. Lim, S. I. Lee, E. Nam, S. H. Park, J. Park, K.-E. Lee, J. O. Park, et al.
Early Concurrent Chemoradiotherapy with Prolonged Oral Etoposide and Cisplatin for Limited-stage Small-cell Lung Cancer
Jpn. J. Clin. Oncol., December 1, 2003; 33(12): 620 - 625.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P.J. Hoskins, K.D. Swenerton, J.A. Pike, P. Lim, C. Aquino-Parsons, F. Wong, and N. Lee
Small-Cell Carcinoma of the Cervix: Fourteen Years of Experience at a Single Institution Using a Combined-Modality Regimen of Involved-Field Irradiation and Platinum-Based Combination Chemotherapy
J. Clin. Oncol., September 15, 2003; 21(18): 3495 - 3501.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R Booton, M Jones, and N Thatcher
Lung cancer * 7: Management of lung cancer in elderly patients
Thorax, August 1, 2003; 58(8): 711 - 720.
[Full Text] [PDF]

Home page
 ThoraxHome page
A Price
Lung cancer * 5: State of the art radiotherapy for lung cancer
Thorax, May 1, 2003; 58(5): 447 - 452.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. M.M. Videtic, L. W. Stitt, A. R. Dar, W. I. Kocha, A. T. Tomiak, P. T. Truong, M. D. Vincent, and E. W. Yu
Continued Cigarette Smoking by Patients Receiving Concurrent Chemoradiotherapy for Limited-Stage Small-Cell Lung Cancer Is Associated With Decreased Survival
J. Clin. Oncol., April 15, 2003; 21(8): 1544 - 1549.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Huang, L. Barbera, M. Brouwers, G. Browman, and W. J. Mackillop
Does Delay in Starting Treatment Affect the Outcomes of Radiotherapy? A Systematic Review
J. Clin. Oncol., February 1, 2003; 21(3): 555 - 563.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. R. Simon and H. Wagner
Small Cell Lung Cancer
Chest, January 1, 2003; 123(1_suppl): 259S - 271S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. G. Spiro and J. C. Porter
Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment
Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1166 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Machtay
The Early Rad Catches the Tumor?
J. Clin. Oncol., July 15, 2002; 20(14): 3045 - 3047.
[Full Text] [PDF]

Home page
 JCOHome page
M. Takada, M. Fukuoka, M. Kawahara, T. Sugiura, A. Yokoyama, S. Yokota, Y. Nishiwaki, K. Watanabe, K. Noda, T. Tamura, et al.
Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104
J. Clin. Oncol., July 15, 2002; 20(14): 3054 - 3060.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J.-H. Lee, J.-H. Lee, J.-H. Ahn, H. Bahng, T.-W. Kim, Y.-K. Kang, K.-H. Lee, J.-C. Kim, C.-S. Yu, J.-H. Kim, et al.
Randomized Trial of Postoperative Adjuvant Therapy in Stage II and III Rectal Cancer to Define the Optimal Sequence of Chemotherapy and Radiotherapy: A Preliminary Report
J. Clin. Oncol., April 1, 2002; 20(7): 1751 - 1758.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. Osterlind
Chemotherapy in small cell lung cancer
Eur. Respir. J., December 1, 2001; 18(6): 1026 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
R. Komaki, M. H. Chasen, W. D. Travis, J. B. Putnam, F. V. Fossella, R. W. Byhardt, and J. Y. Ro
Oncodiagnosis Panel: 1999: Cancer of the Lung: Oncodiagnosis
RadioGraphics, November 1, 2001; 21(6): 1573 - 1596.
[Full Text] [PDF]

Home page
 JCOHome page
T. J. Robnett, M. Machtay, J. P. Stevenson, K. M. Algazy, and S. M. Hahn
Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non-Small-Cell Lung Carcinoma
J. Clin. Oncol., March 1, 2001; 19(5): 1344 - 1349.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
I. S. Woo, Y. S. Park, S. H. Kwon, Y. I. Park, J. A. Lee, M. J. Park, I. G. Hyun, K. S. Jung, H. S. Bae, D. H. Oh, et al.
A Phase II Study of VP-16-Ifosfamide-Cisplatin Combination Chemotherapy Plus Early Concurrent Thoracic Irradiation for Previously Untreated Limited Small Cell Lung Cancer
Jpn. J. Clin. Oncol., December 1, 2000; 30(12): 542 - 546.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. H. Cohen
Thalidomide in the treatment of high-grade gliomas.
J. Clin. Oncol., October 1, 2000; 18(19): 3453 - 3453.
[Full Text] [PDF]

Home page
 JCOHome page
B. Glisson, C. Scott, R. Komaki, B. Movsas, and H. Wagner
Cisplatin, Ifosfamide, Oral Etoposide, and Concurrent Accelerated Hyperfractionated Thoracic Radiation for Patients With Limited Small-Cell Lung Carcinoma: Results of Radiation Therapy Oncology Group Trial 93-12
J. Clin. Oncol., August 16, 2000; 18(16): 2990 - 2995.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Hugli, D. Moro, B. Mermillod, M. Bolla, P. Alberto, H. Bonnefoi, and R. Miralbell
Phase II Trial of Up-Front Accelerated Thoracic Radiotherapy Combined With Chemotherapy and Optional Up-Front Prophylactic Cranial Irradiation in Limited Small-Cell Lung Cancer
J. Clin. Oncol., April 1, 2000; 18(8): 1662 - 1667.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Levitan, A. Dowlati, D. Shina, M. Craffey, W. Mackay, R. DeVore, J. Jett, S. C. Remick, A. Chang, and D. Johnson
Multi-Institutional Phase I/II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Carcinoma
J. Clin. Oncol., March 1, 2000; 18(5): 1102 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. H. Johnson
Management of Small Cell Lung Cancer* : Current State of the Art
Chest, December 1, 1999; 116(suppl_3): 525S - 530S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. B. Marks and G. Sibley
The Rationale and Use of Three-Dimensional Radiation Treatment Planning for Lung Cancer*
Chest, December 1, 1999; 116(suppl_3): 539S - 545S.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. A. Bonner, J. A. Sloan, T. G. Shanahan, B. J. Brooks, R. S. Marks, J. E. Krook, J. B. Gerstner, A. Maksymiuk, R. Levitt, J. A. Mailliard, et al.
Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung Carcinoma
J. Clin. Oncol., September 1, 1999; 17(9): 2681 - 2681.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. Furuse, M. Fukuoka, M. Kawahara, H. Nishikawa, Y. Takada, S. Kudoh, N. Katagami, and Y. Ariyoshi
Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non-Small-Cell Lung Cancer
J. Clin. Oncol., September 1, 1999; 17(9): 2692 - 2692.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. Auperin, R. Arriagada, J.-P. Pignon, C. Le Pechoux, A. Gregor, R. J. Stephens, P. E.G. Kristjansen, B. E. Johnson, H. Ueoka, H. Wagner, et al.
Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
N. Engl. J. Med., August 12, 1999; 341(7): 476 - 484.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. Jeremic, Y. Shibamoto, N. Nikolic, B. Milicic, S. Milisavljevic, A. Dagovic, J. Aleksandrovic, and G. Radosavljevic-Asic
Role of Radiation Therapy in the Combined-Modality Treatment of Patients With Extensive Disease Small-Cell Lung Cancer: A Randomized Study
J. Clin. Oncol., July 1, 1999; 17(7): 2092 - 2092.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. T. Turrisi, K. Kim, R. Blum, W. T. Sause, R. B. Livingston, R. Komaki, H. Wagner, S. Aisner, and D. H. Johnson
Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide
N. Engl. J. Med., January 28, 1999; 340(4): 265 - 271.
[Abstract] [Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 1993 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online